Ghasemzadeh et al. (94) reported in a study population of 599 patients that higher plasma SDF-1α level was associated with a nearly 5- and 6-fold increase in the risk of MI and cardiovascular death, respectively, providing a potentially powerful prognostic tool for patients with CAD. Here, CXCL12 is linked to coronary artery disorder.